Research graph
References from Beyond <scp>CD4</scp> counts: Multi‐biomarker assessment of estimated time since <scp>HIV</scp> ‐1 infection and risk factors for late diagnosis. Local targets link to admitted publications; unresolved targets remain external evidence.
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV‐positive PARTNER taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
10.1016/s0140-6736(19)30418-0 · 2019 · External reference
Antiretroviral therapy for the prevention of HIV‐1 transmission
10.1056/nejmoa1600693 · 2016 · External reference
Prevention of HIV‐1 infection with early antiretroviral therapy
10.1056/nejmoa1105243 · 2011 · External reference
Initiation of antiretroviral therapy in early asymptomatic HIV infection
10.1056/nejmoa1506816 · 2015 · External reference
Estimating the burden of HIV late presentation and its attributable morbidity and mortality across Europe 2010‐2016
10.1186/s12879-020-05261-7 · 2020 · External reference
Risk factors and outcomes for late presentation for HIV‐positive persons in Europe: results from the collaboration of observational HIV epidemiological research Europe study (COHERE)
10.1371/journal.pmed.1001510 · 2013 · External reference
The effect of late presentation on HIV related mortality among adolescents in public hospitals of north showa zone Oromiya, Ethiopia; 2022: a retrospective cohort study
10.1186/s12879-024-09550-3 · 2024 · External reference
Late presentation of HIV infection: a consensus definition
10.1111/j.1468-1293.2010.00857.x · 2011 · External reference
Unresolved reference
External reference
Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 cells/mm3: assessment of need following changes in treatment guidelines
10.1093/cid/cir494 · 2011 · External reference
HIV‐infected long‐term nonprogressors: epidemiology, mechanisms of delayed progression, and clinical and research implications
10.1016/s1286-4579(99)00204-x · 1999 · External reference
Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection
10.1371/journal.pone.0078642 · 2013 · External reference
The immunopathogenesis of human immunodeficiency virus infection
10.1056/nejm199302043280508 · 1993 · External reference
Late presentation to HIV testing is overestimated when based on the consensus definition
10.1111/hiv.12292 · 2016 · External reference
Late diagnosis of HIV: an updated consensus definition
10.1111/hiv.13425 · 2022 · External reference
Determination of mean recency period for estimation of HIV type 1 incidence with the BED‐capture EIA in persons infected with diverse subtypes
10.1089/aid.2010.0159 · 2011 · External reference
Detection of recent HIV‐1 infection using a new limiting‐antigen avidity assay: potential for HIV‐1 incidence estimates and avidity maturation studies
10.1371/journal.pone.0033328 · 2012 · External reference
Ambiguous nucleotide calls from population‐based sequencing of HIV‐1 are a marker for viral diversity and the age of infection
10.1093/cid/ciq164 · 2011 · External reference
Estimating time of HIV‐1 infection from next‐generation sequence diversity
10.1371/journal.pcbi.1005775 · 2017 · External reference
Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals
10.1128/jvi.01960-08 · 2009 · External reference
Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non‐poisson distribution of transmitted variants
10.1128/jvi.02132-08 · 2009 · External reference
Getting more from heterogeneous HIV‐1 surveillance data in a high immigration country: estimation of incidence and undiagnosed population size using multiple biomarkers
10.1093/ije/dyz100 · 2019 · External reference
Combining biomarker and virus phylogenetic models improves HIV‐1 epidemiological source identification
10.1371/journal.pcbi.1009741 · 2022 · External reference
Cohort profile: InfCareHIV, a prospective registry‐based cohort study of people with diagnosed HIV in Sweden
10.1136/bmjopen-2022-069688 · 2023 · External reference
Unresolved reference
External reference
10.2807/1560-7917.es.2024.29.42.2400058
10.2807/1560-7917.es.2024.29.42.2400058 · External reference
A high rate of HIV‐1 acquisition post immigration among migrants in Sweden determined by a CD4 T‐cell decline trajectory model
10.1111/hiv.12509 · 2017 · External reference
Prevalence of HIV indicator conditions in late presenting patients with HIV: a missed opportunity for diagnosis?
10.1093/qjmed/hcy223 · 2019 · External reference
Prevalence and risk factors of late presentation for HIV diagnosis and care in a tertiary referral centre in Switzerland
10.4414/smw.2014.13961 · 2014 · External reference
Risk factors for late HIV diagnosis in the east of England: evidence from national surveillance data and policy implications
10.1177/0956462418793327 · 2019 · External reference
10.1080/23744235.2026.2713548
10.1080/23744235.2026.2713548 · External reference
Deficiencies in the health care system contribute to a high rate of late HIV diagnosis in Sweden
10.1111/hiv.12321 · 2016 · External reference
Prevalence, characteristics and challenges of late HIV diagnosis in Germany: an expert narrative review
10.1007/s15010-023-02064-1 · 2023 · External reference
Late presentation for HIV diagnosis and care in Germany
10.1111/j.1468-1293.2011.00958.x · 2012 · External reference
Profile of new HIV diagnoses and risk factors associated with late diagnosis in a specialized outpatient clinic during the 2014‐2018 period
2020 · External reference
Symptomatic patients without epidemiological indicators of HIV have a high risk of missed diagnosis: a multi‐Centre cross sectional study
10.1371/journal.pone.0162503 · 2016 · External reference
The late‐presenting HIV‐infected patient 30 years after the introduction of HIV testing: spectrum of opportunistic diseases and missed opportunities for early diagnosis
10.1111/hiv.12403 · 2017 · External reference
